ArticleFrontiers in oncology2025
Trends and disparities in the US colorectal cancer mortality, 1999-2023: an analysis of the CDC WONDER database.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fecal Immunochemical Test and Multitarget Stool DNA Testing for Colorectal Cancer Screening in Real-World Practice: A Literature Review.Journal of clinical medicine · 2026Review
- Transoral robotic surgery for salivary carcinomas of the base of tongue: a multicenter REFCOR study.Journal of robotic surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Colorectal cancer (CRC) remains the second leading cause of cancer-related death in the USA. This study systematically assessed the spatiotemporal evolution of CRC mortality from 1999 to 2023 and explored sociodemographic and geographic disparities. Methods: Death-certificate data for adults aged ≥ 25 years were extracted from the CDC WONDER database. CRC deaths were identified using ICD-10 codes C18-C20. Age-adjusted mortality rates (AAMR) were calculated with the 2000 US standard population. Stratified analyses were performed by age, sex, race/ethnicity, census region, state, and National Center for Health Statistics urban-rural classification. Joinpoint regression estimated annual percent change (APC) and average annual percent change (AAPC). Results: AAMR rose annually by 0.45% in the 25-34-year group and 1.03% in the 35-44-year group but declined significantly among individuals ≥ 55 years (AAPC -1.43% to -3.20%). Adults ≥ 75 years accounted for more than half of CRC deaths. The South registered the highest AAMR (21.13 per 100,000), whereas the Northeast had the lowest (17.31 per 100,000). Non-Hispanic Black individuals experienced the highest AAMR (24.90 per 100,000). Nonmetropolitan counties showed higher AAMR (23.16 per 100,000) than metropolitan counties (18.69 per 100,000). Conclusion: Despite an overall decline in US CRC mortality, rising risk among young adults and pronounced disparities across regions, racial/ethnic groups, and urban-rural settings persist. Targeted screening and intervention strategies for younger populations, high-burden areas, and vulnerable groups are essential to accelerate equitable reductions in CRC mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.